Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
137310.KS Stock Summary
Top 10 Correlated ETFs
137310.KS
In the News
137310.KS Financial details
Company Rating
Neutral
Market Cap
1551.36B
Income
-467.45B
Revenue
655.68B
Book val./share
22489.86
Cash/share
4542.01
Dividend
-
Dividend %
-
Employees
576
Optionable
No
Shortable
Yes
Earnings
15 May 2023
P/E
-1.74
Forward P/E
42.6
PEG
0.12
P/S
2.02
P/B
0.42
P/C
2.6
P/FCF
6
Quick Ratio
-
Current Ratio
2.14
Debt / Equity
0.15
LT Debt / Equity
0.09
-
-
EPS (TTM)
-4.34K
EPS next Y
277
EPS next Q
-122.49
EPS this Y
-146.89%
EPS next Y
-106.39%
EPS next 5Y
-106.39%
EPS last 5Y
NAN%
Revenue last 5Y
55.14%
Revenue Q/Q
5.68%
EPS Q/Q
45.85%
-
-
-
-
SMA20
-5.26%
SMA50
3.14%
SMA100
19.32%
Inst Own
-
Inst Trans
-
ROA
-18%
ROE
-24%
ROC
-0.11%
Gross Margin
-
Oper. Margin
-52%
Profit Margin
-100%
Payout
-10%
Shs Outstand
122.35M
Shs Float
34.41M
-
-
-
-
Target Price
-
52W Range
9570.0-25450.0
52W High
-53.63%
52W Low
+23.3%
RSI
49.45
Rel Volume
0.35
Avg Volume
253.97K
Volume
87.94K
Perf Week
1.29%
Perf Month
-2.4%
Perf Quarter
10.49%
Perf Half Y
7.57%
-
-
-
-
Beta
1.122
-
-
Volatility
313.8%, 545.62%
Prev Close
-0.25%
Price
11800
Change
-2.32%
137310.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 879.29 | 18.07K | 30.04K | 28.94K | 5.6K | |
Net income per share | 38 | 6.6K | 11.16K | 9K | -4.18K | |
Operating cash flow per share | -19.58 | 5.31K | 12.66K | 8.79K | -2.19K | |
Free cash flow per share | -110 | 4.72K | 11.65K | 5.82K | -3.49K | |
Cash per share | 473.32 | 4.98K | 19.44K | 20.43K | 5.01K | |
Book value per share | 1.61K | 8.02K | 22.46K | 29.07K | 24.82K | |
Tangible book value per share | 1.59K | 8.06K | 22.2K | 28.42K | 16.22K | |
Share holders equity per share | 1.61K | 8.02K | 22.46K | 29.07K | 24.82K | |
Interest debt per share | 178.72 | 224.3 | 261.04 | 254.5 | 4.17K | |
Market cap | 5061.69B | 5692.56B | 5451.43B | 2897.15B | 1275.99B | |
Enterprise value | 5057.07B | 5469.84B | 4594.81B | 1048.99B | 1218.04B | |
P/E ratio | 1.61K | 9.25 | 5.01 | 3.18 | -2.75 | |
Price to sales ratio | 69.37 | 3.38 | 1.86 | 0.99 | 2.06 | |
POCF ratio | -3.12K | 11.49 | 4.41 | 3.25 | -5.27 | |
PFCF ratio | -554.55 | 12.93 | 4.8 | 4.91 | -3.3 | |
P/B Ratio | 37.94 | 7.61 | 2.49 | 0.98 | 0.46 | |
PTB ratio | 37.94 | 7.61 | 2.49 | 0.98 | 0.46 | |
EV to sales | 69.31 | 3.24 | 1.57 | 0.36 | 1.96 | |
Enterprise value over EBITDA | 880.06 | 7.53 | 3.16 | 0.81 | -11.02 | |
EV to operating cash flow | -3.11K | 11.04 | 3.72 | 1.18 | -5.03 | |
EV to free cash flow | -554.05 | 12.42 | 4.05 | 1.78 | -3.15 | |
Earnings yield | 0 | 0.11 | 0.2 | 0.31 | -0.36 | |
Free cash flow yield | 0 | 0.08 | 0.21 | 0.2 | -0.3 | |
Debt to equity | 0.11 | 0.03 | 0.01 | 0.01 | 0.15 | |
Debt to assets | 0.09 | 0.01 | 0.01 | 0.01 | 0.11 | |
Net debt to EBITDA | -0.8 | -0.31 | -0.59 | -1.42 | 0.52 | |
Current ratio | 3.72 | 1.87 | 3.31 | 8.48 | 3.01 | |
Interest coverage | 6.04 | 1.7K | 2.79K | 1.15K | -5.62 | |
Income quality | -0.52 | 0.8 | 1.16 | 0.98 | 0.52 | |
Dividend Yield | 0 | 0 | 0.01 | 0.07 | 0.02 | |
Payout ratio | 0 | 0 | 0.05 | 0.22 | -0.06 | |
Sales general and administrative to revenue | 0.02 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.07 | 0.01 | 0.01 | 0.02 | 0.1 | |
Intangibles to total assets | 0.03 | 0 | 0.01 | 0.02 | 0.32 | |
Capex to operating cash flow | 4.62 | -0.11 | -0.08 | -0.34 | 0.6 | |
Capex to revenue | -0.1 | -0.03 | -0.03 | -0.1 | -0.23 | |
Capex to depreciation | -1.73 | -6.92 | -5.19 | -7.36 | -1.05 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0.01 | 0 | |
Graham number | 1.17K | 34.49K | 75.11K | 76.7K | 48.31K | |
ROIC | 0.01 | 0.81 | 0.45 | 0.28 | -0.08 | |
Return on tangible assets | 0.02 | 0.42 | 0.37 | 0.29 | -0.18 | |
Graham Net | 597.47 | 3.08K | 15.63K | 20K | 87.06 | |
Working capital | 78.67B | 599.86B | 1798.11B | 2220.29B | 644.22B | |
Tangible asset value | 132.34B | 752.03B | 2165.36B | 2879.41B | 1798.62B | |
Net current asset value | 75.77B | 585.16B | 1776.26B | 2202.12B | 187.22B | |
Invested capital | 0.11 | 0.03 | 0.01 | 0.01 | 0.15 | |
Average receivables | 0 | 245.9B | 407.91B | 274.84B | 185.45B | |
Average payables | 0 | 220.66B | 281.98B | 89.94B | 38.62B | |
Average inventory | 0 | 200.34B | 345.4B | 289.55B | 225.14B | |
Days sales outstanding | 166.43 | 99.26 | 44.51 | 23.95 | 105 | |
Days payables outstanding | 83.93 | 189.26 | 36.13 | 10.73 | 19.88 | |
Days of inventory on hand | 240.12 | 161.5 | 87.08 | 60.4 | 121.6 | |
Receivables turnover | 2.19 | 3.68 | 8.2 | 15.24 | 3.48 | |
Payables turnover | 4.35 | 1.93 | 10.1 | 34.01 | 18.36 | |
Inventory turnover | 1.52 | 2.26 | 4.19 | 6.04 | 3 | |
ROE | 0.02 | 0.82 | 0.5 | 0.31 | -0.17 | |
Capex per share | -90.42 | -590.97 | -1.02K | -2.97K | -1.31K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.94K | 1.78K | 1.59K | 1.3K | 1.02K | |
Net income per share | -3.21K | -2.17K | -806.25 | -551.57 | -768.2 | |
Operating cash flow per share | 2.67K | -704.95 | -586.42 | -866.07 | -78.06 | |
Free cash flow per share | 2.09K | -1.15K | -877 | -1.24K | -283.01 | |
Cash per share | 20.35K | 7.66K | 6.46K | 4.09K | 4.54K | |
Book value per share | 28.95K | 27.2K | 26.52K | 25.14K | 22.49K | |
Tangible book value per share | 28.31K | 7.29K | 6.92K | 7.48K | 14.7K | |
Share holders equity per share | 28.95K | 27.2K | 26.52K | 25.14K | 22.49K | |
Interest debt per share | 246.9 | 7.07K | 6.98K | 3.93K | 3.5K | |
Market cap | 2908.85B | 2158.28B | 1251.24B | 1321.69B | 1408.22B | |
Enterprise value | 1060.69B | 2230.26B | 1461.3B | 1453.03B | 1350.26B | |
P/E ratio | -2.23 | -2.43 | -3.79 | -5.15 | -3.75 | |
Price to sales ratio | 14.74 | 11.83 | 7.69 | 8.75 | 11.31 | |
POCF ratio | 10.72 | -29.93 | -20.86 | -13.13 | -147.44 | |
PFCF ratio | 13.67 | -18.3 | -13.95 | -9.13 | -40.67 | |
P/B Ratio | 0.99 | 0.78 | 0.46 | 0.45 | 0.51 | |
PTB ratio | 0.99 | 0.78 | 0.46 | 0.45 | 0.51 | |
EV to sales | 5.37 | 12.23 | 8.99 | 9.62 | 10.85 | |
Enterprise value over EBITDA | -3.27 | -105.72 | 40.93 | 37.48 | 101.31 | |
EV to operating cash flow | 3.91 | -30.93 | -24.36 | -14.43 | -141.38 | |
EV to free cash flow | 4.99 | -18.91 | -16.29 | -10.04 | -39 | |
Earnings yield | -0.11 | -0.1 | -0.07 | -0.05 | -0.07 | |
Free cash flow yield | 0.07 | -0.05 | -0.07 | -0.11 | -0.02 | |
Debt to equity | 0.01 | 0.25 | 0.26 | 0.15 | 0.15 | |
Debt to assets | 0.01 | 0.17 | 0.18 | 0.12 | 0.11 | |
Net debt to EBITDA | 5.7 | -3.41 | 5.88 | 3.39 | -4.35 | |
Current ratio | 8.48 | 2.48 | 1.68 | 2.14 | 3.01 | |
Interest coverage | -352.13 | -4.84 | -5.27 | -4.02 | -3.09 | |
Income quality | -0.83 | 0.32 | 0.72 | 1.58 | 0.1 | |
Dividend Yield | 0 | 0 | 0.02 | 0 | 0 | |
Payout ratio | 0 | 0 | -0.36 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.56 | 0.69 | 0.55 | 0 | |
Research and developement to revenue | 0.07 | 0.08 | 0.1 | 0.11 | 0.12 | |
Intangibles to total assets | 0.02 | 0.48 | 0.5 | 0.54 | 0.32 | |
Capex to operating cash flow | -0.22 | 0.64 | 0.5 | 0.44 | 2.63 | |
Capex to revenue | -0.3 | -0.25 | -0.18 | -0.29 | -0.2 | |
Capex to depreciation | -4.23 | -1.7 | -0.9 | -1.27 | -0.58 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Graham number | 45.72K | 36.48K | 21.94K | 17.66K | 19.72K | |
ROIC | -0.03 | -0.05 | -0.02 | -0.01 | -0.01 | |
Return on tangible assets | -0.1 | -0.1 | -0.04 | -0.04 | -0.04 | |
Graham Net | 19.92K | -2.85K | -3.02K | -1.32K | 78.88 | |
Working capital | 2220.29B | 808.06B | 464.21B | 488.75B | 644.22B | |
Tangible asset value | 2879.41B | 745.38B | 707.51B | 869.15B | 1798.62B | |
Net current asset value | 2202.12B | -74.38B | -118.93B | 13.32B | 187.22B | |
Invested capital | 0.01 | 0.25 | 0.26 | 0.15 | 0.15 | |
Average receivables | 409.23B | 231.17B | 243.8B | 213.02B | 193.45B | |
Average payables | 94B | 50.81B | 44.47B | 31.25B | 30.96B | |
Average inventory | 349.76B | 277.41B | 285.6B | 255.22B | 217.52B | |
Days sales outstanding | 87.72 | 133.2 | 120.45 | 124.18 | 129.06 | |
Days payables outstanding | 16.22 | 24.93 | 23.09 | 23.99 | 35.21 | |
Days of inventory on hand | 91.3 | 132.75 | 192.16 | 191.93 | 215.34 | |
Receivables turnover | 1.03 | 0.68 | 0.75 | 0.72 | 0.7 | |
Payables turnover | 5.55 | 3.61 | 3.9 | 3.75 | 2.56 | |
Inventory turnover | 0.99 | 0.68 | 0.47 | 0.47 | 0.42 | |
ROE | -0.11 | -0.08 | -0.03 | -0.02 | -0.03 | |
Capex per share | -575.03 | -448.22 | -290.58 | -378.85 | -204.95 |
137310.KS Frequently Asked Questions
What is SD BioSensor, Inc stock symbol ?
SD BioSensor, Inc is a KR stock and trading under the symbol 137310.KS
What is SD BioSensor, Inc stock quote today ?
SD BioSensor, Inc stock price is $11800 today.
Is SD BioSensor, Inc stock public?
Yes, SD BioSensor, Inc is a publicly traded company.